At a glance
ClinicalIndex Comparison RecordN/ACompleted· 71 enrolled
Drug / intervention
Atropine (0.01%) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment Effect of Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate as Classified by Electro-retinal Responses
In Brief
A clinical study evaluating Atropine (0.01%) and Artificial tear for Myopia. Completed, enrolled 71 participants across 1 site.
Detailed Summary
Our project is a 24-month longitudinal randomized controlled trial that aims to investigate the myopia development after topical application of 0.01% atropine in children with either fast or slow myopia progression classified according to their initial electro-retinal responses. This will help elucidate the effectiveness of using low concentration atropine for myopia control in children with different myopia progression rates.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesHong Kong
CollaboratorsThe University of Hong Kong
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 2017
Enrollment StartFeb 2018
Primary CompletionDec 2019
Study CompletionAug 2020
TodayJul 2026
First PostedDec 15, 2017
Enrollment StartFeb 1, 2018
Primary CompletionDec 31, 2019
Study CompletionAug 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.5 years ago
Interventions
Atropine (0.01%)drug
tropical application
Artificial teardrug
tropical application